• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于正电子发射断层扫描的硼中子俘获疗法,使用硼苯丙氨酸治疗高级别胶质瘤:第一部分。

Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.

作者信息

Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R

机构信息

Department of Neurosurgery, Kyoto Prefectural University of Medicine, Japan.

出版信息

Clin Cancer Res. 1998 Aug;4(8):1825-32.

PMID:9717808
Abstract

Determination of tumor boron-10 (10B) levels is required for accurate neutron dosimetry during boron neutron capture therapy. We assessed a new method for quantitative measurement of boronated drug uptake in high-grade gliomas. This method uses positron emission tomography (PET) with fluorine-18-labeled L-fluoroborono-phenylalanine (L-18F-10B-FBPA), which was synthesized as an analogue of L-boronophenylalanine. We studied the accumulation of L-18F-10B-FBPA by PET in patients with high-grade gliomas. Dynamic PET studies of brain tumors revealed that L-18F-10B-FBPA accumulated gradually after bolus injection, and the value of PET activity divided by the integrated plasma activity reached a constant level 42 min after injection, which was defined as the incorporation constant (Ic*). This constant reflected the appropriate L-18F-10B-FBPA accumulation in tumor tissue. Based on the Ic* constant, the methods for estimating tumor 10B concentration were devised. With this method, the estimated values of 10B concentration in gliomas were very close to the 10B levels in surgical specimens. This method was based solely on PET and can potentially provide data that would assist in the selection of patients for future treatment with boron neutron capture therapy after surgical resection of their brain tumors.

摘要

在硼中子俘获治疗期间,为了进行精确的中子剂量测定,需要测定肿瘤硼 - 10(¹⁰B)水平。我们评估了一种定量测量高级别胶质瘤中硼化药物摄取的新方法。该方法使用正电子发射断层扫描(PET)和氟 - 18标记的L - 氟硼苯丙氨酸(L - ¹⁸F - ¹⁰B - FBPA),它是作为L - 硼苯丙氨酸的类似物合成的。我们通过PET研究了L - ¹⁸F - ¹⁰B - FBPA在高级别胶质瘤患者中的蓄积情况。对脑肿瘤的动态PET研究显示,静脉推注后L - ¹⁸F - ¹⁰B - FBPA逐渐蓄积,注射后42分钟PET活性值除以血浆活性积分达到恒定水平,该水平被定义为掺入常数(Ic*)。这个常数反映了L - ¹⁸F - ¹⁰B - FBPA在肿瘤组织中的适当蓄积。基于Ic*常数,设计了估计肿瘤¹⁰B浓度的方法。使用这种方法,胶质瘤中¹⁰B浓度的估计值与手术标本中的¹⁰B水平非常接近。该方法仅基于PET,有可能提供有助于选择在脑肿瘤手术切除后接受硼中子俘获治疗的患者的数据。

相似文献

1
Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.基于正电子发射断层扫描的硼中子俘获疗法,使用硼苯丙氨酸治疗高级别胶质瘤:第一部分。
Clin Cancer Res. 1998 Aug;4(8):1825-32.
2
Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.基于正电子发射断层扫描的硼中子俘获疗法使用硼苯丙氨酸治疗高级别胶质瘤:第二部分。
Clin Cancer Res. 1998 Aug;4(8):1833-41.
3
Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.氟-18标记的氟硼代苯丙氨酸PET在胶质瘤患者中的应用
J Nucl Med. 1998 Feb;39(2):325-33.
4
Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.氟硼代苯丙氨酸正电子发射断层扫描在胶质瘤患者中的预后及治疗指标
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5888-95.
5
Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.在具有高渗性血脑屏障破坏的荷胶质瘤大鼠模型中评估4-硼基-2-(18)F-氟-L-苯丙氨酸用于硼中子俘获治疗的药代动力学
J Nucl Med. 2005 Nov;46(11):1858-65.
6
PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.正电子发射断层扫描(PET)药代动力学分析以估计肿瘤和大脑中的硼浓度,作为规划恶性脑胶质瘤硼中子俘获治疗(BNCT)的指导。
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S348-50. doi: 10.1016/j.apradiso.2009.03.061. Epub 2009 Mar 27.
7
Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.正电子发射断层扫描与[18F]BPA:一种用于评估硼中子俘获疗法中肿瘤硼摄取的潜在应用。
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S351-4. doi: 10.1016/j.apradiso.2009.03.062. Epub 2009 Apr 2.
8
Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.评估4-硼-2-¹⁸F-氟-L-苯丙氨酸-果糖作为荷胶质瘤大鼠模型中硼中子俘获疗法探针的性能。
J Nucl Med. 2004 Feb;45(2):302-8.
9
A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.利用正电子发射断层扫描和4-硼-2-[¹⁸F]氟-L-苯丙氨酸对4-[¹⁰B]硼-L-苯丙氨酸在肿瘤组织中进行独特的体内评估,用于恶性黑色素瘤的硼中子俘获治疗。
Melanoma Res. 1992 Sep;2(3):171-9. doi: 10.1097/00008390-199209000-00005.
10
Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.使用氟-18标记的硼苯丙氨酸和正电子发射断层扫描改进多形性胶质母细胞瘤的硼中子俘获治疗计划。
Med Phys. 2002 Oct;29(10):2351-8. doi: 10.1118/1.1507780.

引用本文的文献

1
MRI and F-BPA PET-guided targeting in boron neutron capture therapy.硼中子俘获治疗中MRI与F-BPA PET引导下的靶向定位
Sci Rep. 2025 Aug 25;15(1):31285. doi: 10.1038/s41598-025-14642-4.
2
First Experiences of Pilot Clinical Studies on Boron Neutron Capture Therapy for Recurrent Gastrointestinal Cancers Using an Intravenous Injection of BPA.使用静脉注射双丙叉丙酮(BPA)对复发性胃肠道癌症进行硼中子俘获疗法的试点临床研究的初步经验。
In Vivo. 2025 May-Jun;39(3):1470-1491. doi: 10.21873/invivo.13948.
3
Correlation between L-amino acid transporter 1 expression and 4-borono-2- F-fluoro-phenylalanine accumulation in humans.
L-氨基酸转运蛋白 1 表达与人 4-硼基-2-氟苯丙氨酸蓄积的相关性。
Cancer Med. 2023 Nov;12(21):20564-20572. doi: 10.1002/cam4.6635. Epub 2023 Oct 25.
4
Boron Neutron Capture Therapy: Clinical Application and Research Progress.硼中子俘获治疗:临床应用与研究进展。
Curr Oncol. 2022 Oct 18;29(10):7868-7886. doi: 10.3390/curroncol29100622.
5
Improved Stability and Practicality for Synthesis of 4-Borono-2-[F]fluoro-l-phenylalanine by Combination of [O]O Single-Use and [F]CHCOOF Labeling Agents.通过[O]O一次性使用和[F]CHCOOF标记剂相结合提高4-硼代-2-[F]氟-L-苯丙氨酸合成的稳定性和实用性。
Nucl Med Mol Imaging. 2022 Apr;56(2):86-95. doi: 10.1007/s13139-021-00719-1. Epub 2022 Feb 8.
6
A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond.放射治疗的批判性综述:从粒子束治疗(质子、碳离子和硼中子俘获治疗)到其他治疗方法。
J Pers Med. 2021 Aug 23;11(8):825. doi: 10.3390/jpm11080825.
7
Development of an Imaging Technique for Boron Neutron Capture Therapy.硼中子俘获治疗的成像技术的发展。
Cells. 2021 Aug 19;10(8):2135. doi: 10.3390/cells10082135.
8
Diffuse bone marrow uptake related to granulocyte colony-stimulating factor-producing maxillary sinus carcinoma on 4-borono-2-F-fluoro-L-phenylalanine positron emission tomography/computed tomography.4-硼-2-F-氟-L-苯丙氨酸正电子发射断层扫描/计算机断层扫描显示与产生粒细胞集落刺激因子的上颌窦癌相关的弥漫性骨髓摄取。
World J Nucl Med. 2020 Oct 23;20(2):188-191. doi: 10.4103/wjnm.WJNM_80_20. eCollection 2021 Apr-Jun.
9
4-Borono-2-F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research.用于硼中子俘获疗法导向诊断的4-硼-2-氟-L-苯丙氨酸PET:二十五年研究综述
Ann Nucl Med. 2019 Apr;33(4):223-236. doi: 10.1007/s12149-019-01347-8. Epub 2019 Feb 28.
10
Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas - A Pilot Study.硼中子俘获疗法联合早期连续使用贝伐单抗治疗复发性恶性胶质瘤——一项试点研究。
Neurol Med Chir (Tokyo). 2018 Dec 15;58(12):487-494. doi: 10.2176/nmc.oa.2018-0111. Epub 2018 Nov 21.